Video: JRS Pharma – The global MCC manufacturing network
Discover JRS PHARMA's industry leading manufacturing network for Microcrystalline Cellulose.
List view / Grid view
Discover JRS PHARMA's industry leading manufacturing network for Microcrystalline Cellulose.
A new vaccine platform using self-assembling peptide nanofibres tagged with antigens has been tested successfully in mice, eliciting a strong immune response.
Robust and sensitive, the PyroMAT® Monocyte Activation Test system is a non-animal based method for the detection of endotoxin and non-endotoxin pyrogens. Download our studies
This whitepaper from NSF explains how to conduct an efficient and effective review and approval of incident reports.
Quality control testing instrumentation solutions for GMP manufacturing. From raw materials QC through production QC and final product QC.
This whitepaper from Beckman Coulter discusses GMP Cleanrooms Classification and Routine Environmental Monitoring.
This whitepaper from Beckman Coulter explores GMP cleanroom routine environmental monitoring and data integrity.
Maintaining Data Integrity. Did you know that lack of data integrity has been a top reason for FDA Drug GMP warning letters?
The new MET ONE 3400+ Series PortableAirborne Particle Counter automates environmental monitoring for GMP cleanroom compliance.
Q Biomed entered into a Named Patient Programme distribution agreement for Strontium89, a non-opioid metastatic bone cancer pain drug.
This article explores what pharmaceutical companies could be doing to promote injectable biosimilar approval and consumer uptake.
The cervical dysplasia drug-device product, APL-1702 (Cevira®), offers an alternative to surgery and has been approved to start a clinical trial in China and several other countries.
Scientists unveil their model, which other researchers can use to test the injectability of their drug delivering microparticle designs in silico.
The sustainable device, consisting of food industry by-products, had excellent biocompatibility both in vitro and in vivo.
The FDA has given approval to Phesgo for injection under the skin to treat HER2-positive breast cancer, meaning it can be administered at home by a healthcare professional.